Merz Pharmaceuticals

Q: What is Merz Pharmaceuticals's official website?

Merz Pharmaceuticals's official website is www.cuvposa.com

Q: What is Merz Pharmaceuticals's Revenue?

Merz Pharmaceuticals's revenue is <$5 Million

Q: What is Merz Pharmaceuticals's SIC code?

Merz Pharmaceuticals's SIC: 28,283

Q: What is Merz Pharmaceuticals's NAICS code?

Merz Pharmaceuticals's NAICS: 32,325

Q: How many employees does Merz Pharmaceuticals have?

Merz Pharmaceuticals has 11-50 employees

Q: What industry does Merz Pharmaceuticals belong to?

Merz Pharmaceuticals is in the industry of: Manufacturing , Pharmaceuticals

Q: What technology does Merz Pharmaceuticals use?

Some of the popular technologies that Merz Pharmaceuticals uses are: WordPress.org, reCAPTCHA, Google Font API, Google Tag Manager

Q: What does Merz Pharmaceuticals do?

Merz is a healthcare company that specializes in providing solutions for pediatric patients, particularly focusing on managing chronic severe drooling (sialorrhea) associated with neurological conditions in children aged 3 to 16 years. Their primary product, CUVPOSA, is an oral solution intended to reduce excessive drooling, while offering resource... s and support for healthcare professionals. The company emphasizes the importance of safety information and prescribing guides for medical practitioners. Merz is dedicated to ensuring the well-being of their pediatric clients through effective treatments and comprehensive support. Read More

Q: Is Merz Pharmaceuticals a public company?

Merz Pharmaceuticals is private company therefore does not currently have an official ticker symbol

Manufacturing · United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

United States

Website

www.cuvposa.com

Revenue

<$5 Million

Industry

Manufacturing

Pharmaceuticals

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About Merz Pharmaceuticals

Merz is a healthcare company that specializes in providing solutions for pediatric patients, particularly focusing on managing chronic severe drooling (sialorrhea) associated with neurological conditions in children aged 3 to 16 years. Their primary product, CUVPOSA, is an oral solution intended to reduce excessive drooling, while offering resources and support for healthcare professionals. The company emphasizes the importance of safety information and prescribing guides for medical practitioners. Merz is dedicated to ensuring the well-being of their pediatric clients through effective treatments and comprehensive support.Explore more

Is this data correct?

Popular SearchesMerz Pharmaceuticals LLCCuvposaSIC Code 28,283NAICS Code 32,325Show more

Is Merz Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Merz Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic

Product Launch: Get notified when Merz Pharmaceuticals launches new products

Check if Merz Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!

Earning: See what the market has to say on Merz Pharmaceuticals recently announced quarterly report

Click to see if Merz Pharmaceuticals had a recent Job posting/layoffs

Check out if Merz Pharmaceuticals is spiking on competitors!

Website visits: Recent activity has been detected on your website

Funding: Get notified immidiatlly once Merz Pharmaceuticals has new funding data

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Congratulate Masked Content for being promoted to Masked Content at Merz Pharmaceuticals

Recommended Actions

Reach out to Masked Content who joined Merz Pharmaceuticals as Masked Content

Find more new buyers

View Email Formats for Merz Pharmaceuticals

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Merz Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Merz Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Merz Pharmaceuticals.